Aurobindo Pharma Fourth Quarter Profit Jumps 40%; Shares Rise 4%

The company's shares rose as much as 4 per cent to Rs 786.80 in early trade on Tuesday, while the broader market was down 0.15 per cent

Sensex Keeps Its Chin Up, Bounces 126 Points On Value-buying

The 30-share barometer was up 125.76 points, or 0.50 per cent, at 25,227.49, with sectoral indices in healthcare, capital goods, auto, banking, FMCG, power and IT leading the recovery, rising by up to 0.92 per cent.

US, EU Regulators Urge Indian Drug Companies To Step Up Standards

India supplies about 33 per cent of the medicines sold in the United States, and nearly a quarter sold in the UK

Sun Pharma Q3 Profit Beats Street, To Wind Down JV With Merck

The company posts net earnings for the quarter ended December 31 of Rs 1,417 crore, compared with Rs 1,425 crore a year earlier

Sun Pharma Raises Rs 1,000 Cr Via NCDs

Drug major Sun Pharmaceutical Industries today said it has raised Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis.

Sensex Gets Cracking Again, Jumps 217 Points On Global Cues

The bulls firmly took back control on Monday after a day's pause as the benchmark Sensex sprinted almost 217 points to 25,735.90 driven by a rally in banking, and metal stocks and firm overseas leads

FDA Revokes Approval For Sun Pharma's Seizure Drug Over Compliance Issues

Sun Pharma To Sell 2 Ranbaxy Marketing Divisions To Strides Arcolab

Sun Pharma Acquires InSite Vision In $48 Million Deal

Sun Pharma Looking To Divest Ireland Plant

Sun Pharma June Quarter Net Down 60%

Sensex Rebounds By 323 Points; Sun Pharma, RIL Lead Rally

Sensex Ends Lower Amid Choppy Trade; Sun Pharma, ITC Drag

Sun Pharma Expects Revenue, Profit To Continue Under Stress In FY 16 Due To Integration Charges

Sun Pharma Expects Ranbaxy Costs To Hit 2016 Revenue